Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.
Penketh PG, Finch RA, Sauro R, Baumann RP, Ratner ES, Shyam K. Penketh PG, et al. Among authors: sauro r. Chem Biol Drug Des. 2018 Jan;91(1):62-74. doi: 10.1111/cbdd.13057. Epub 2017 Jul 17. Chem Biol Drug Des. 2018. PMID: 28636806 Free PMC article.
Experimental setups for FEL-based four-wave mixing experiments at FERMI.
Bencivenga F, Zangrando M, Svetina C, Abrami A, Battistoni A, Borghes R, Capotondi F, Cucini R, Dallari F, Danailov M, Demidovich A, Fava C, Gaio G, Gerusina S, Gessini A, Giacuzzo F, Gobessi R, Godnig R, Grisonich R, Kiskinova M, Kurdi G, Loda G, Lonza M, Mahne N, Manfredda M, Mincigrucci R, Pangon G, Parisse P, Passuello R, Pedersoli E, Pivetta L, Prica M, Principi E, Rago I, Raimondi L, Sauro R, Scarcia M, Sigalotti P, Zaccaria M, Masciovecchio C. Bencivenga F, et al. Among authors: sauro r. J Synchrotron Radiat. 2016 Jan;23(1):132-40. doi: 10.1107/S1600577515021104. Epub 2016 Jan 1. J Synchrotron Radiat. 2016. PMID: 26698055
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
Di Lorenzo E, Sauro R, Capasso M, Lanni F, Lanzillo T, Carbone G, Manganelli F, Palmieri V, Serino V, Pagliuca MR, Rosato G, Suryapranata H, De Luca G. Di Lorenzo E, et al. Among authors: sauro r. Int J Cardiol. 2016 Jan 1;202:177-82. doi: 10.1016/j.ijcard.2015.08.123. Epub 2015 Aug 16. Int J Cardiol. 2016. PMID: 26397405 Clinical Trial.
Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
De Luca G, Sauro R, Capasso M, Lanzillo T, Manganelli F, Carbone G, Lanni F, Pagliuca MR, Palmieri V, Serino V, Rosato G, Suryapranata H, Di Lorenzo E. De Luca G, et al. Among authors: sauro r. Diab Vasc Dis Res. 2015 Sep;12(5):306-14. doi: 10.1177/1479164115592252. Epub 2015 Jul 6. Diab Vasc Dis Res. 2015. PMID: 26150193 Free article. Clinical Trial.
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Carbone G, Lanni F, Pagliuca MR, Stanco G, Rosato G, Suryapranata H, De Luca G. Di Lorenzo E, et al. Among authors: sauro r. JACC Cardiovasc Interv. 2014 Aug;7(8):849-56. doi: 10.1016/j.jcin.2014.02.016. JACC Cardiovasc Interv. 2014. PMID: 25147029 Free article. Clinical Trial.
22 results